Джозеф Меркола - Кето-диета. Революционная система питания, которая поможет похудеть и «научит» ваш организм превращать жиры в энергию

13. P. J. Cox, K. Clarke, “Acute Nutritional Ketosis: Implications for Exercise Performance and Metabolism,” Extreme Physiology & Medicine, 3 (2014): 1, DOI: 10.1186/2046-7648-3-17.

14. О. E. Owen et al., “Liver and Kidney Metabolism During Prolonged Starvation,” Journal of Clinical Investigation, 48, no. 3 (1969): 574–583.

15. M. Akram, “A Focused Review of the Role of Ketone Bodies in Health and Disease,” Journal of Medicinal Food, 16, no. 11 (November 2013): 965–967, DOI: 10.1089/jmf.2012.2592.

16. Там же.

17. Phinney and Volek, The Art and Science of Low-Carbohydrate Living, 10.

18. Interview with Jeff Volek, Ph.D., http://articles.mercola.com/sites/articles/ar-chive/2016/01/31 /high-fat-low-carb-diet-benefits.aspx, accessed 12/2/16.

19. J. C. Newman and E. Verdin, “(3-hydroxybutyrate: Much More Than a Metabolite,” Diabetes Research and Clinical Practice, 106, no. 2 (2014): 173–181, DOI: 10.1016/j. diabres.2014.08.009.

20. A. Paoli et al., “Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases,” BioMed Research International, 2014 (2014), DOI: 10.1155/2014/474296.

21. M. A. McNally and A. L. Hartman, “Ketone Bodies in Epilepsy,” Journal of Neurochemistry, 121, no. 1 (2012): 28–35, DOI: 10.1111/j.l471-4159.2012.07670.x.

22. J. Moore, Keto Clarity (Victory Belt Publishing, 2014), 58.

23. A. J. Brown, “Low-Carb Diets, Fasting and Euphoria: Is There a Link between Ketosis and Gamma-hydroxybutyrate (GHB)?” Medical Hypotheses, 68, no. 2 (2007): 268–271, DOI: 10.1016/j.mehy.2006.07.043.

1. E. L. Knight et al., “The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency,” Annals of Internal Medicine, 138. no. 6 (2003): 460–467, DOI: 10.7326/0003-4819-138-6-200303180-00009.

2. M. I. Frisard et al., “Effect of 6-Month Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals: A Randomized Controlled Trial,” http://jamanetwork.com/journals/jama/fullarti-cle/1108368.

3. M. E. Levine et al., “Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population,” Cell Metabolism, 19, no. 3 (2014): 407–417, DOI: 10.1016/j. cmet.2014.02.006.

4. J. Guevara-Aguirre et al., “Growth Hormone Receptor Deficiency Is Associated With a Major Reduction in Pro-aging Signaling, Cancer and Diabetes in Humans,” Science Translational Medicine, 3, no. 70 (2011): 70, DOI: 10.1126/ scitranslmed.3001845.

5. S. I. A. Apelo and D. W. Lamming, “Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island,” Journal of Gerontology, 71, no. 7 (2016): 841–849, DOI: 10.1093/gerona/glw090.

6. S. M. Solon-Biet et al., “The Ratio of Macronutrients, Not Caloric Intake, Dictates Cardiometabolic Health, Aging, and Longevity in Ad Libi-tum-Fed Mice,” Cell Metabolism, 19, no. 3 (2014): 418–430, DOI: 10.1016/j. cmet.2014.02.009.

1. “Ferritin: The Test,” American Association for Clinical Chemistry, https://labtest-sonline.org/understanding/analytes/ferritin/tab/test/, accessed May 9, 2016.

2. E. D. Weinberg, “The Hazards of Iron Loading,” Metallomics, 2, no. 11 (November, 2010): 732–740, DOI: 10.1039/c0mt00023j.

3. M. D. Beaton and P. C. Adams, “Treatment of Hyperferritinemia,” Annals of Hepatology, 11, no. 3 (2012): 294–300, PMID: 22481446.

4. G. Ortiz-Estrada et al., “Iron-Saturated Lactoferrin and Pathogenic Protozoa: Could This Protein Be an Iron Source for Their Parasitic Style of Life?” Future Microbiology, 7, no. 1 (2012): 149–164, DOI: 10.2217/fmb. 11.140.

5. D. }. Fleming et al., “Dietary Factors Associated with the Risk of High Iron Stores in the Elderly Framingham Heart Study Cohort,” American Journal of Clinical Nutrition, 76, no. 6 (2002): 1375–1384, PMID: 12450906.

6. T. Iwasaki et al, “Serum Ferritin Is Associated with Visceral Fat Area and Subcutaneous Fat Area,” Diabetes Care, 28, no. 10 (2005): 2486–2491, PMID: 16186284.

7. S. К. Park et al., “Association between Serum Ferritin Levels and the Incidence of Obesity in Korean Men: A Prospective Cohort Study” Endocrine Journal, 61, no. 3 (2014): 215–224, DOI: 10.1507/endocrj.EJ13-0173.

8. Там же.

9. J. M. Fernandez-Real et al., “Serum Ferritin as a Component of the Insulin Resistance Syndrome,” Diabetes Care, 21, no. 1 (1998): 62–68, DOI: 10.2337/dia-care.21.1.62.

10. J. Montonen et al., “Body Iron Stores and Risk of Type 2 Diabetes: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study,” Diabetologia , 55, no. 10 (2012): 2613–2621, DOI: 10.1007/s00125-012-2633-y.

11. J. M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart, “Iron Stores, Blood Donation, and Insulin Sensitivity and Secretion,” Clinical Chemistry, 51, no. 7 (June 2005): 1201–1205, DOI: 10.1373/clinchem.2004.046847.

12. B. J. Van Lenten et al., “Lipid-Induced Changes in Intracellular Iron Homeostasis in Vitro and in Vivo,” Journal of Clinical Investigation, 95, no. 5 (1995): 2104–2110, DOI: 10.1172/JCI117898.

13. N. Stadler, R. A. Lindner, and M. J. Davies, “Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper,” Arteriosclerosis, Thrombosis, and Vascular Biology, 24 (2004): 949–954, DOI: 10.1161/01. ATV.0000124892.90999.cb.

14. W. B. Kannel et al., “Menopause and Risk of Cardiovascular Disease: The Framingham Study,” Annals of Internal Medicine, 85 (1976): 447–452, DOI: 10.7326/0003-4819-85-4-447.

15. M. A. Lovell et al., “Copper, Iron and Zinc in Alzheimer’s Disease Senile Plaques,” Journal of the Neurological Sciences, 158, no. 1 (June 11, 1998): 47–52, DOI: 10.1016/S0022-510X(98)00092-6.

16. K. Jellinger et al., “Brain Iron and Ferritin in Parkinsons and Alzheimer’s diseases,” Journal of Neural Transmission, 2 (1990): 327, DOI: 10.1007/BF02252926.

17. G. Bartzokis et al., “Brain Ferritin Iron as a Risk Factor for Age at Onset in Neuro-degenerative Diseases,” Annals of the New York Academy of Sciences, 1012 (2004): 224–236, DOI: 10.1196/annals.l306.019.

18. S. Ayton et al., “Ferritin Levels in the Cerebrospinal Fluid Predict Alzheimer’s Disease Outcomes and Are Regulated by APOE,” Nature Communications, 6 (2015): 6760, DOI: 10.1038/ncomms7760.

19. W. Z. Zhu et al., “Quantitative MR Phase-Corrected Imaging to Investigate Increased Brain Iron Deposition of Patients with Alzheimer’s Disease,” Radiology, 253 (2009): 497–504, DOI: 10.1148/radiol.2532082324.

20. A. A. Alkhateeb and J. R. Connor, “The Significance of Ferritin in Cancer: Anti-Oxidation, Inflammation and Tumorigenesis,” Biochimica et Biophysica Acta , 1836, no. 2 (Dec 2013): 245–254, DOI: 10.1016/j.bbcan.2013.07.002.

21. J. I. Wurzelmann et al, “Iron Intake and the Risk of Colorectal Cancer,” Cancer Epidemiology, Biomarkers and Prevention, 5, no. 7 (July 1, 1996): 503–507. PMID: 8827353.

22. Y. Deugnier, “Iron and Liver Cancer,” Alcohol, 30, no. 2 (2003): 145–150.

23. L. R. Zacharski et al., “Decreased Cancer Risk after Iron Reduction in Patients with Peripheral Arterial Disease: Results from a Randomized Trial,” JNCI: Journal of National Cancer Institute, 100, no. 14 (2008): 996-1002, DOI: 10.1093/jnci/ djn209.

24. L. Valenti et al., “Association between Iron Overload and Osteoporosis in Patients with Hereditary Hemochromatosis,” Osteoporosis International, 20, no. 4 (April, 2009): 549–555, DOI: 10.1007/s00198-008-0701-4.

25. “Hemochromatosis,” National Institute of Diabetes and Digestive and Kidney Disease (2016), http://www.niddk.nih.gov/health-information/ health-topics/liver-disease/hemochromatosis/Pages/facts.aspx, accessed May 9, 2016.

26. “Welcome,” Iron Disorders Institute (2016), http://www.hemochromatosis. org/#symptoms, accessed May 9, 2016.

27. “Serum Iron Test,” MedlinePlus Medical Encyclopedia (2016), https://www.nlm. nih.gov/medlineplus/ency/article/003488.htm, accessed May 9, 2016.

28. “TIBC, UIBC, and Transferrin Test: Iron Binding Capac

ity; IBC; Serum Iron Binding Capacity; Siderophilin; Total Iron Binding Capacity; Unsaturated Iron Binding Capacity,” Lab Tests

Online (2016), https://labtestsonline.org/understanding/analytes/tibc/tab/ test/, accessed May 9, 2016.

29. L. Zacharski, “Ferrotoxic Disease: The Next Great Public Health Challenge,” Clinical Chemistry, 60, no. 11 (November 2014): 1362–1364, DOI: 10.1373/ clinchem.2014.231266.

30. P. Mangan, Dumping Iron: How to Ditch This Secret Killer and Reclaim Your Health, Phalanx Press, 2016, locations 308–312.

31. Там же, locations 1353–1356.

32. Там же, locations 1609–1612.

33. Там же, locations 416–418.

34. Там же, locations 428–431.

35. Там же, locations 582–595.

1. С. Manisha Chandalia et al, “Beneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes Mellitus,” New England Journal of Medicine, 342 (2000): 1392–1398, DOI: 10.1056/NEJM200005113421903.

2. M. Wien et al, “A Randomized 3x3 Crossover Study to Evaluate the Effect of Hass Avocado Intake on Post-ingestive Satiety, Glucose and Insulin Levels, and Subsequent Energy Intake in Overweight Adults,” Nutrition Journal, 12 (2013): 155, DOI: 10.1186/1475-2891-12-155.

3. “Potassium,” University of Maryland Medical Center, http://umm.edu/health/med-ical/altmed/supplement/potassium, accessed November 28, 2016.

4. M. E. Cogswell et al., “Sodium and Potassium Intakes among U.S. Adults: NHANES 2003–2008,” The American Journal of Clinical Nutrition, 96, no. 3 (2012): 647–657, DOI: 10.3945/ajcn.l 12.034413.

5. M. L. Dreher and A. J. Davenport, “Hass Avocado Composition and Potential-Health Effects,” Critical Reviews in Food Science and Nutrition, 53, no. 7 (2013): 738–750, DOI: 10.1080/10408398.2011.556759.

6. R. E. Kopec et al., “Avocado Consumption Enhances Human Postprandial Provitamin A Absorption and Conversion from a Novel High-(3-Carotene Tomato Sauce and from Carrots,” Journal of Nutrition, 8 (2014), DOI: 10.3945/jn.l 13.187674.

7. N. Z. Unlu et al., “Carotenoid Absorption from Salad and Salsa by Humans Is Enhanced by the Addition of Avocado or Avocado Oil,” Journal of Nutrition, 135, no. 3 (2005): 431–436.

8. E. A. Lee et al, “Targeting Mitochondria with Avocatin В Induces Selective Leukemia Cell Death,” Cancer Research, 7Ъ, no. 12 (June 15 2015): 2478–2488, DOI: 10.1158/0008-5472.CAN-14-2676.

9. M. Notarnicola et al., “Effects of Olive Oil Polyphenols on Fatty Acid Synthase Gene Expression and Activity in Human Colorectal Cancer Cells,” Genes & Nutrition, 6, no. 1 (2011): 63–69, DOI: 10.1007/sl2263-010-0177-7.

10. A. Canuelo et al., “Tyrosol, a Main Phenol Present in Extra Virgin Olive Oil, Increases Lifespan and Stress Resistance in Caenorhabditis Elegans,” Mechanisms of Ageing and Development, 133, no. 8 (2012): 563–574, DOI: 10.1016/j. mad.2012.07.004.